Mo1406 Functional Role of 18F-FDG PET/CT Scan in Diabetic Patients With Pancreatic Ductal Adenocarcinomas

Abstract

G A A b st ra ct s a nephroblastoma) and tuberculosis in 32 (47 %), 26 (38 %), 4 (5 %), 3 (4 %), 1 (1.4 %), 1 (1.4 %) and 1 (1.4 %) pts respectively. NET were G1 and G2 in 81 and 19 % respectively. Lymph-node metastases were present in 4 G1 NET (1.5 %), 3 pts with adenocarcinoma (75%), 2 with SPPT (6%) and in the pt with pancreatoblastoma. Surgical procedure consisted of Whipple procedure, distal pancreatectomy with splenectomy, median pancreatectomy, enucleation and total pancreatectomy in 30 (44 %), 10 (15 %), 19 (28 %), 7 (10 %) and 2 (3 %) pts, respectively. Postoperative and 1-year mortality was nil. Postoperative morbidity was 22 %. Six (9 %) and 3 (4 %) pts had exocrine or endocrine pancreatic insufficiency at 1 year, respectively. Conclusion Solid pancreatic tumors are most often asymptomatic in subjects below 40 years of age. Accurate preoperative diagnosis is made in 3 pts out of 4, EUS-FNB being highly accurate. Solid pseudopapillary and neuroendocrine tumors account for more than 80 % of the tumors. Short and most-term surgical results are excellent.